-
admin
Posts
Baseus posts strong 2024 H1 sales on Amazon Japan with new flagship products
TOKYO, July 19, 2024 /PRNewswire/ — Baseus, a leading global brand of consumer electronics and mobile phone accessories, has achieved remarkable success on Amazon Japan,...
China Mount Taishan Tianping Lake Tourist Center Opens
TAIAN, China, July 19, 2024 /PRNewswire/ — This is a report from the Shandong Office of Hong Kong Business Daily. Recently, the opening ceremony of...
CommerceIQ Publishes Proprietary Data Insights from Prime Day 2024
Amazon revenues nearly tripled compared to the previous week, as brands came prepared to win – and upsell – Prime Day shoppers PALO ALTO, Calif.,...
Abbey Romeo of Love on the Spectrum Partners with MakerPlace by Michaels to Launch Exclusive Hand-Knit Capsule Collection
The partnership highlights the purpose that hand-making adds to the lives of neurodivergent creators, spotlighting additional artisans through Abbey’s Picks. IRVING, Texas, July 18, 2024...
Vitamin C Market to Reach USD 2.99 Billion by 2032 Driven by the use of Vitamin C in Various Cosmetics in the Form of Serums and Moisturizers | Report by SNS Insider
The Vitamin C market will be experiencing rapid growth due to increased demand for the personal care and cosmetics industry. The capacity to stimulate the...
Secondary Packaging Market Size Expected to Reach USD 366.81 Bn by 2032
The global secondary packaging market size is calculated at USD 253.06 billion in 2024 and is expected to reach around USD 366.81 billion by 2032,...
Santiago Calatrava and John Zils to Receive 2024 Lifetime Achievement Awards from Council on Tall Buildings and Urban Habitat
Chicago, July 18, 2024 (GLOBE NEWSWIRE) — The Council on Tall Buildings and Urban Habitat (CTBUH) today announced the winner of its 2024 Lynn S....
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and...
Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease
– Independent committee confirms FALCON study is powered for potential success with both alternative endpoints passing futility- -Committee confirms strong safety profile of KL1333- –...
Appili Therapeutics Announces Second Amendment to Arrangement Agreement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, July 18, 2024 (GLOBE NEWSWIRE) — Appili...